These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33493383)
41. The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients. Prado-Garcia H; Romero-Garcia S; Puerto-Aquino A; Rumbo-Nava U Cancer Immunol Immunother; 2017 Jun; 66(6):765-776. PubMed ID: 28289860 [TBL] [Abstract][Full Text] [Related]
42. Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas. Otsubo K; Sakai H; Kimura H; Miyazawa T; Marushima H; Kojima K; Furuya N; Mineshita M; Chosokabe M; Koike J; Saji H Thorac Cancer; 2021 Dec; 12(23):3169-3176. PubMed ID: 34655161 [TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions. Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505 [TBL] [Abstract][Full Text] [Related]
50. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849 [TBL] [Abstract][Full Text] [Related]
51. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology. Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331 [TBL] [Abstract][Full Text] [Related]
52. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology. Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174 [TBL] [Abstract][Full Text] [Related]
53. Cell-blocks are suitable material for programmed cell death ligand-1 immunohistochemistry: Comparison of cell-blocks and matched surgical resection specimens in lung cancer. Pak MG; Roh MS Cytopathology; 2019 Nov; 30(6):578-585. PubMed ID: 31209979 [TBL] [Abstract][Full Text] [Related]
54. Prognostic and clinicopathological utility of programmed death-ligand 1 in malignant pleural mesothelioma: A meta-analysis. Zhang F; Gong W Int Immunopharmacol; 2020 Jun; 83():106481. PubMed ID: 32339986 [TBL] [Abstract][Full Text] [Related]
56. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. de Perrot M; Wu L; Cabanero M; Perentes JY; McKee TD; Donahoe L; Bradbury P; Kohno M; Chan ML; Murakami J; Keshavjee S; Tsao MS; Cho BCJ J Thorac Cardiovasc Surg; 2020 May; 159(5):2082-2091.e1. PubMed ID: 31866087 [TBL] [Abstract][Full Text] [Related]
57. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion. Tseng YH; Ho HL; Lai CR; Luo YH; Tseng YC; Whang-Peng J; Lin YH; Chou TY; Chen YM J Thorac Oncol; 2018 Mar; 13(3):447-453. PubMed ID: 29246835 [TBL] [Abstract][Full Text] [Related]
58. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. Berg KB; Churg AM; Cheung S; Dacic S Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740 [TBL] [Abstract][Full Text] [Related]
59. Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. Carosio R; Fontana V; Mastracci L; Ferro P; Grillo F; Banelli B; Canessa PA; Dessanti P; Vigani A; Morabito A; Pfeffer U; Poggi A; Roncella S; Pistillo MP J Cancer Res Clin Oncol; 2021 Feb; 147(2):459-468. PubMed ID: 33216211 [TBL] [Abstract][Full Text] [Related]
60. EBUS-FNA cytologic-histologic correlation of PD-L1 immunohistochemistry in non-small cell lung cancer. Jug R; Giovacchini CX; Liu B; Green CL; Clarke JM; Mahmood K; Pavlisko EN J Am Soc Cytopathol; 2020; 9(6):485-493. PubMed ID: 32336671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]